MENU
+Compare
ZNTL
Stock ticker: NASDAQ
AS OF
Mar 3, 04:59 PM (EDT)
Price
$1.91
Change
-$0.16 (-7.73%)
Capitalization
147.52M

ZNTL Zentalis Pharmaceuticals Forecast, Technical & Fundamental Analysis

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers... Show more

ZNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ZNTL with price predictions
Feb 28, 2025

Momentum Indicator for ZNTL turns negative, indicating new downward trend

ZNTL saw its Momentum Indicator move below the 0 level on February 27, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned negative. In of the 87 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZNTL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ZNTL entered a downward trend on February 13, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ZNTL's RSI Oscillator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for ZNTL just turned positive on February 06, 2025. Looking at past instances where ZNTL's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ZNTL advanced for three days, in of 280 cases, the price rose further within the following month. The odds of a continued upward trend are .

ZNTL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.385) is normal, around the industry mean (11.857). P/E Ratio (0.000) is within average values for comparable stocks, (80.120). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.578). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (3.351) is also within normal values, averaging (242.214).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ZNTL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZNTL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ZNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ZNTL is expected to report earnings to rise 48.07% to -82 cents per share on March 03

Zentalis Pharmaceuticals ZNTL Stock Earnings Reports
Q4'24
Est.
$-0.83
Q3'24
Beat
by $0.05
Q2'24
Missed
by $0.40
Q1'24
Beat
by $0.91
Q4'23
Est.
$-0.86
The last earnings report on November 06 showed earnings per share of -56 cents, beating the estimate of -60 cents. With 310.62K shares outstanding, the current market capitalization sits at 147.52M.
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1359 Broadway
Phone
+1 212 433-3791
Employees
168
Web
https://www.zentalis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCCRX16.280.19
+1.18%
MassMutual Small Cap Opps R3
MLOIX8.360.09
+1.09%
Cohen & Steers Future of Energy I
FEYCX26.220.22
+0.85%
Fidelity Advisor Asset Manager 85% C
SVPIX105.570.73
+0.70%
ProFunds Small Cap Value Inv
JEMMX9.25-0.09
-0.96%
JHancock Emerging Markets Equity I

ZNTL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with MDGL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
+2.48%
MDGL - ZNTL
51%
Loosely correlated
+1.65%
ORMP - ZNTL
43%
Loosely correlated
-0.48%
NGNE - ZNTL
40%
Loosely correlated
+3.45%
NRIX - ZNTL
40%
Loosely correlated
+3.00%
VCYT - ZNTL
39%
Loosely correlated
+2.72%
More